Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.

ABSTRACT:

Background

Current consensus recommendations are to not initiate cervical cancer screening for immunocompetent adolescent females before 21 years of age. This is in part because of the very low rate of 0.8 per 100,000 new cervical cancer cases diagnosed among women aged between 20 to 24 years. Timely human papillomavirus vaccination further decreases the incidence of cervical cancer to 4 cases per 100,000 persons by the age of 28 years. Screening before 21 years of age has demonstrated no clear benefit in cancer risk reduction or outcomes. In addition, unindicated screening among adolescents can lead to patient harm and increasing costs to the healthcare system.

Objective

It is important to assess the rates of overutilization of cervical cancer screening and to identify area

SUBMITTER: Hosier H 

PROVIDER: S-EPMC8633062 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature